The current financial score of Health In Tech Inc is 6.79. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 8.06M, representing a year-over-year decrease of 13.50%, while its net profit experienced a year-over-year decrease of 498.18%.
The current valuation score of Health In Tech Inc is 9.70. Its current P/E ratio is -63.65, which is -1006.45% below the recent high of 576.95 and -49.08% above the recent low of -94.89.
The current earnings forecast score of Health In Tech Inc is 8.00. The average price target is 3.70, with a high of 4.10 and a low of 3.00.
The current price momentum score of Health In Tech Inc is 3.96. Currently, the stock price is trading between the resistance level at 0.99 and the support level at 0.82, making it suitable for range-bound swing trading.
The current institutional shareholding score of Health In Tech Inc is 3.00. The latest institutional shareholding proportion is 5.94%, representing a quarter-over-quarter increase of 52.24%.
The current risk assessment score of Health In Tech Inc is 2.95. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.